Fluticasone Furoate | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Fluticasone Furoate
Health Canada Patents

PharmaCompass Sponsored Ads

Contact Supplier

Vamsi Labs Fluticasone Furoate

Contact Supplier

Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Contact Supplier

PharmaCompass Sponsored Ads

Contact Supplier

Fluticasone Furoate

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Fluticasone Furoate

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

26 API Suppliers, 12 USDMF, 4 CEP/COS, 2 JDMF, 3 EU WC, 1 KDMF, 20 NDC API, 20 Listed Suppliers, $ API Reference Price

26 API Suppliers
12 USDMF
4 CEP/COS
2 JDMF
3 EU WC
1 KDMF
20 NDC API
20 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

11 Drugs in Development

11 Drugs in Development

INTERMEDIATES

1 Intermediate Suppliers

1 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

108 FDF Dossiers, 9 FDA Orange Book, 80 Europe, 7 Canada, 4 Australia, 5 South Africa, 3 Listed Dossiers

108 FDF Dossiers
9 FDA Orange Book
80 Europe
7 Canada
4 Australia
5 South Africa
3 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

POWDER;INHALATION - 0.05MG/INH;EQ 0.025MG BASE/INH, POWDER;INHALATION - 0.1MG/INH;EQ 0.025MG BASE/INH, POWDER;INHALATION - 0.2MG/INH;EQ 0.025MG BASE/INH, POWDER;INHALATION - 0.05MG/INH, POWDER;INHALATION - 0.1MG/INH, POWDER;INHALATION - 0.2MG/INH, SPRAY, METERED;NASAL - 0.0275MG/SPRAY

POWDER;INHALATION - 0.05MG/INH;EQ 0.025MG BASE/INH
POWDER;INHALATION - 0.1MG/INH;EQ 0.025MG BASE/INH
POWDER;INHALATION - 0.2MG/INH;EQ 0.025MG BASE/INH
POWDER;INHALATION - 0.05MG/INH
POWDER;INHALATION - 0.1MG/INH
POWDER;INHALATION - 0.2MG/INH
SPRAY, METERED;NASAL - 0.0275MG/SPRAY

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 1 SPI Pharma, 1 DKSH, 2 Faran Shimi Pharmaceutical, 3 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 4 Actylis, 2 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 BASF, 4 DFE Pharma, 1 Finar, 6 Gangwal Chemicals, 1 Ideal Cures Pvt Ltd, 17 Kerry, 1 Kima Chemical, 12 Microlex e.U, 1 Nanjing Bold Chemical, 1 Pharmatrans-Sanaq, 2 Pluviaendo, 2 Prachin Chemical, 7 Roquette, 6 Seppic, 2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 9 Sigachi Industries, 1 The Dow Chemical Company, 2 Vasa Pharmachem

1 Rochem International Inc
1 SPI Pharma
1 DKSH
2 Faran Shimi Pharmaceutical
3 Gangwal Healthcare
2 Nanjing Well Pharmaceutical
4 Actylis
2 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
1 BASF
4 DFE Pharma
1 Finar
6 Gangwal Chemicals
1 Ideal Cures Pvt Ltd
17 Kerry
1 Kima Chemical
12 Microlex e.U
1 Nanjing Bold Chemical
1 Pharmatrans-Sanaq
2 Pluviaendo
2 Prachin Chemical
7 Roquette
6 Seppic
2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd
9 Sigachi Industries
1 The Dow Chemical Company
2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

37 Fillers, Diluents & Binders, 16 Thickeners and Stabilizers, 15 Solubilizers, 12 Direct Compression, 9 Lubricants & Glidants, 8 Co-Processed Excipients, 8 Granulation, 7 Parenteral, 5 Rheology Modifiers, 5 Disintegrants & Superdisintegrants, 4 Emulsifying Agents, 4 Coating Systems & Additives, 4 Film Formers & Plasticizers, 3 Topical, 3 Controlled & Modified Release, 2 Surfactant & Foaming Agents, 2 Chewable & Orodispersible Aids, 2 Taste Masking, 1 API Stability Enhancers

37 Fillers, Diluents & Binders
16 Thickeners and Stabilizers
15 Solubilizers
12 Direct Compression
9 Lubricants & Glidants
8 Co-Processed Excipients
8 Granulation
7 Parenteral
5 Rheology Modifiers
5 Disintegrants & Superdisintegrants
4 Emulsifying Agents
4 Coating Systems & Additives
4 Film Formers & Plasticizers
3 Topical
3 Controlled & Modified Release
2 Surfactant & Foaming Agents
2 Chewable & Orodispersible Aids
2 Taste Masking
1 API Stability Enhancers

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 53 NEWS #PharmaBuzz

1 DATA COMPILATION #PharmaFlow
53 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 73 Finished Drug Prices, 35 Annual Reports

2 US Medicaid Prescriptions
73 Finished Drug Prices
35 Annual Reports

MARKET PLACE

6 APIs

6 APIs

PATENTS & EXCLUSIVITIES

111 US Patents, 5 US Exclusivities, 5 Health Canada Patents

111 US Patents
5 US Exclusivities
5 Health Canada Patents

$ API Ref.Price (USD/KG) : 41,762 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

5 All

01 5GlaxoSmithKline Inc.

filter Patent Reset all filters

5 All

01 52417825

filter Product Reset all filters

5 All

01 4FLUTICASONE FUROATE

02 1Fluticasone Furoate

filter Dosage Reset all filters

5 All

01 1Nasal Spray

02 4POWDER

filter Exp Date Reset all filters

5 All

01 52021-08-03

EUROAPI Fluticasone

Product Main Page

01

GlaxoSmithKline Inc.

Fluticasone Furoate

PharmScience R&D

Not Confirmed

GlaxoSmithKline Inc.

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2021-08-03

Date Granted : 2008-07-22

Fluticasone Furoate

Brand Name : AVAMYS

Patent Number : 2417825

Filing Date : 2001-08-03

Strength per Unit : 27.5 mcg per spray

Dosage Form : Nasal Spray

Human Or VET : Human

Route of Administration : Intranasal

Patent Expiration Date : 2021-08-03

Date Granted : 2008-07-22

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

GlaxoSmithKline Inc.

Fluticasone Furoate

PharmScience R&D

Not Confirmed

GlaxoSmithKline Inc.

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2021-08-03

Date Granted : 2008-07-22

Fluticasone Furoate

Brand Name : ARNUITY ELLIPTA

Patent Number : 2417825

Filing Date : 2001-08-03

Strength per Unit : 100 mcg

Dosage Form : POWDER

Human Or VET : Human

Route of Administration : INHALATION

Patent Expiration Date : 2021-08-03

Date Granted : 2008-07-22

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

GlaxoSmithKline Inc.

Fluticasone Furoate

PharmScience R&D

Not Confirmed

GlaxoSmithKline Inc.

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2021-08-03

Date Granted : 2008-07-22

Fluticasone Furoate

Brand Name : ARNUITY ELLIPTA

Patent Number : 2417825

Filing Date : 2001-08-03

Strength per Unit : 100 mcg

Dosage Form : POWDER

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2021-08-03

Date Granted : 2008-07-22

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

GlaxoSmithKline Inc.

Fluticasone Furoate

PharmScience R&D

Not Confirmed

GlaxoSmithKline Inc.

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2021-08-03

Date Granted : 2008-07-22

Fluticasone Furoate

Brand Name : ARNUITY ELLIPTA

Patent Number : 2417825

Filing Date : 2001-08-03

Strength per Unit : 200 mcg

Dosage Form : POWDER

Human Or VET : Human

Route of Administration : INHALATION

Patent Expiration Date : 2021-08-03

Date Granted : 2008-07-22

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

GlaxoSmithKline Inc.

Fluticasone Furoate

PharmScience R&D

Not Confirmed

GlaxoSmithKline Inc.

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2021-08-03

Date Granted : 2008-07-22

Fluticasone Furoate

Brand Name : ARNUITY ELLIPTA

Patent Number : 2417825

Filing Date : 2001-08-03

Strength per Unit : 200 mcg

Dosage Form : POWDER

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2021-08-03

Date Granted : 2008-07-22

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
ASK US!